Cargando…
Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma
The management of conjunctival melanoma is challenging due to the more frequent local recurrence and metastasis compared to other conjunctival neoplasms. Locally advanced conjunctival melanoma may require an orbital exenteration, and treatment options for metastatic conjunctival melanoma have been l...
Autores principales: | Sa, Ho-Seok, Daniel, Claire, Esmaeli, Bita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PUBLISHED BY KNOWLEDGE E
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493425/ https://www.ncbi.nlm.nih.gov/pubmed/36160103 http://dx.doi.org/10.18502/jovr.v17i3.11579 |
Ejemplares similares
-
Immune Checkpoint Inhibitor Therapy for Orbital and Ocular Adnexal Squamous Cell Carcinomas: International Society of Ocular Oncology President's Lecture, 2022
por: Esmaeli, Bita
Publicado: (2023) -
Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update
por: Vukadin, Sonja, et al.
Publicado: (2021) -
Conjunctival melanoma with orbital invasion and liver metastasis managed with systemic immune checkpoint inhibitor therapy
por: Chang, Michael, et al.
Publicado: (2019) -
Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies
por: Gkiala, Anastasia, et al.
Publicado: (2020) -
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project
por: Bakhoum, Mathieu F., et al.
Publicado: (2019)